Misplaced Pages

Fentonium bromide

Clinical data
ATC code	A03BB04 (WHO)
Pharmacokinetic data
Bioavailability	1
Identifiers
IUPAC name -8-azoniabicyclooctan-3-yl] 3-hydroxy-2-phenylpropanoate bromide
CAS Number	5868-06-4
PubChem CID	71534
DrugBank	DB08978
UNII	XS152O7VCZ
ECHA InfoCard	100.025.018
Chemical and physical data
Formula	C31H34BrNO4
Molar mass	564.520 g·mol
(what is this?)  (verify)

Fentonium bromide (INN) is an anticholinergic and antispasmodic atropine derivative. In the US its patent number is 3,356,682. It is sold by Sanofi-Aventis and Zambon.

References

1. Milne GW (2002). "Fentonium bromide". Drugs: Synonyms and Properties (2nd ed.). Aldershot, Hampshire, England: Ashgate. p. 2785. ISBN 978-0-566-08491-1.
2. "Fentonium". DrugBank. 17 August 2016. Retrieved 19 December 2016.
3. "Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices". sdrugs.com. Retrieved 19 December 2016.

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Tropanes
• Quaternary ammonium compounds
• Bromides
• Aromatic ketones
• Primary alcohols
• Carboxylate esters
• Biphenyls
• Muscarinic antagonists
• Gastrointestinal system drug stubs